Skip to main content
. 2022 Jan 18;13(2):2927–2942. doi: 10.1080/21655979.2021.2017698

Figure 3.

Figure 3.

miR-665-3p agomir facilitates NAFLD progression in mice. (a) HE and oil red O staining of liver tissues. (b) Hepatic levels of TG, TC and NEFA. (c) Quantification of the liver weight and liver weight/tibial length. (d) Hepatic hydroxyproline levels. (e) Serum ALT and AST levels. All results were expressed as the means ± standard deviations, n = 6 for each group, and *P < 0.05 was considered statistically significant.